{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:40:57Z","timestamp":1791592857312,"version":"4.3.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005224","name":"Deutsches Zentrum f\u00fcr Neurodegenerative Erkrankungen","doi-asserted-by":"publisher","award":["BN012"],"award-info":[{"award-number":["BN012"]}],"id":[{"id":"10.13039\/501100005224","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Early identification of individuals at risk of dementia is mandatory to implement prevention strategies and design clinical trials that target early disease stages. Subjective cognitive decline (SCD) and neuropsychiatric symptoms (NPS) have been proposed as potential markers for early manifestation of Alzheimer\u2019s disease (AD). We aimed to investigate the frequency of NPS in SCD, in other at-risk groups, in healthy controls (CO), and in AD patients, and to test the association of NPS with AD biomarkers, with a particular focus on cognitively unimpaired participants with or without SCD-related worries.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We analyzed data of <jats:italic>n<\/jats:italic>\u2009=\u2009687 participants from the German DZNE Longitudinal Cognitive Impairment and Dementia (DELCODE) study, including the diagnostic groups SCD (<jats:italic>n<\/jats:italic>\u2009=\u2009242), mild cognitive impairment (MCI, <jats:italic>n<\/jats:italic>\u2009=\u2009115), AD (<jats:italic>n<\/jats:italic>\u2009=\u200977), CO (<jats:italic>n<\/jats:italic>\u2009=\u2009209), and first-degree relatives of AD patients (REL, <jats:italic>n<\/jats:italic>\u2009=\u200944). The Neuropsychiatric Inventory Questionnaire (NPI-Q), Geriatric Depression Scale (GDS-15), and Geriatric Anxiety Inventory (GAI-SF) were used to assess NPS. We examined differences of NPS frequency between diagnostic groups. Logistic regression analyses were carried out to further investigate the relationship between NPS and cerebrospinal fluid (CSF) AD biomarkers, focusing on a subsample of cognitively unimpaired participants (SCD, REL, and CO), who were further differentiated based on reported worries.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The numbers of reported NPS, depression scores, and anxiety scores were significantly higher in subjects with SCD compared to CO. The quantity of reported NPS in subjects with SCD was lower compared to the MCI and AD group. In cognitively unimpaired subjects with worries, low A\u00df42 was associated with higher rates of reporting two or more NPS (OR 0.998, 95% CI 0.996\u20131.000, <jats:italic>p<\/jats:italic>\u2009&lt;\u2009.05).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>These findings give insight into the prevalence of NPS in different diagnostic groups, including SCD and healthy controls. NPS based on informant report seem to be associated with underlying AD pathology in cognitively unimpaired participants who worry about cognitive decline.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Trial registration<\/jats:title>\n<jats:p>German Clinical Trials Register <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.drks.de\/drks_web\/setLocale_EN.do\">DRKS00007966<\/jats:ext-link>. Registered 4 May 2015.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13195-020-00701-7","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T11:03:09Z","timestamp":1602846189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers\u2014results from the DELCODE study"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1072-9375","authenticated-orcid":false,"given":"Lena","family":"Sannemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Katrin","family":"Schild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slawek","family":"Altenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Brosseron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Buerger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoleta Carmen","family":"Cosma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Fliessbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silka Dawn","family":"Freiesleben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzel","family":"Glanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Heneka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Janowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Kilimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xenia","family":"Kobeleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Laske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coraline D.","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias H. J.","family":"Munk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Perneczky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Polcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Priller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Rauchmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"R\u00f6sch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janna","family":"Rudolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Spottke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike Jakob","family":"Spruth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Teipel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Vukovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Wolfsgruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emrah","family":"Duezel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Jessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the DELCODE Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,16]]},"reference":[{"key":"701_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, et al. Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol. 2013;12:357\u201367. https:\/\/doi.org\/10.1016\/S1474-4422(13)70044-9.","journal-title":"Lancet Neurol"},{"key":"701_CR2","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/J.JALZ.2011.05.2410","volume":"7","author":"CG Lyketsos","year":"2011","unstructured":"Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J, et al. Neuropsychiatric symptoms in Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:532\u20139. https:\/\/doi.org\/10.1016\/J.JALZ.2011.05.2410.","journal-title":"Alzheimers Dement"},{"key":"701_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000112509","volume":"25","author":"LG Apostolova","year":"2008","unstructured":"Apostolova LG, Cummings JL. Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature. Dement Geriatr Cogn Disord. 2008;25:115\u201326. https:\/\/doi.org\/10.1159\/000112509.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"701_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3233\/JAD-2009-1120","volume":"18","author":"R Monastero","year":"2009","unstructured":"Monastero R, Mangialasche F, Camarda C, Ercolani S, Camarda R. A systematic review of neuropsychiatric symptoms in mild cognitive impairment. J Alzheimers Dis. 2009;18:11\u201330. https:\/\/doi.org\/10.3233\/JAD-2009-1120.","journal-title":"J Alzheimers Dis"},{"key":"701_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13195-020-00604-7","volume":"12","author":"TM Liew","year":"2020","unstructured":"Liew TM. Neuropsychiatric symptoms in cognitively normal older persons, and the association with Alzheimer\u2019s and non-Alzheimer\u2019s dementia. Alzheimers Res Ther. 2020;12:35. https:\/\/doi.org\/10.1186\/s13195-020-00604-7.","journal-title":"Alzheimers Res Ther"},{"key":"701_CR6","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1590\/S1980-57642009DN20400004","volume":"2","author":"FE Taragano","year":"2008","unstructured":"Taragano FE, Allegri RF, Lyketsos C, Taragano FE, Allegri RF, Lyketsos C. Mild behavioral impairment: a prodromal stage of dementia. Dement Neuropsychol. 2008;2:256\u201360. https:\/\/doi.org\/10.1590\/S1980-57642009DN20400004.","journal-title":"Dement Neuropsychol"},{"key":"701_CR7","doi-asserted-by":"publisher","first-page":"584","DOI":"10.4088\/JCP.08m04181","volume":"70","author":"FE Taragano","year":"2009","unstructured":"Taragano FE, Allegri RF, Krupitzki H, Sarasola DR, Serrano CM, Lo\u00f1 L, et al. Mild behavioral impairment and risk of dementia: a prospective cohort study of 358 patients. J Clin Psychiatry. 2009;70:584\u201392.","journal-title":"J Clin Psychiatry"},{"key":"701_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1001\/archpsyc.63.3.273","volume":"63","author":"DE Barnes","year":"2006","unstructured":"Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffe K. Depressive symptoms, vascular disease, and mild cognitive impairment. Arch Gen Psychiatry. 2006;63:273. https:\/\/doi.org\/10.1001\/archpsyc.63.3.273.","journal-title":"Arch Gen Psychiatry"},{"key":"701_CR9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/J.JAGP.2013.01.006","volume":"21","author":"PB Rosenberg","year":"2013","unstructured":"Rosenberg PB, Mielke MM, Appleby BS, Oh ES, Geda YE, Lyketsos CG. The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. Am J Geriatr Psychiatry. 2013;21:685\u201395. https:\/\/doi.org\/10.1016\/J.JAGP.2013.01.006.","journal-title":"Am J Geriatr Psychiatry"},{"key":"701_CR10","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1176\/appi.ajp.2014.13060821","volume":"171","author":"YE Geda","year":"2014","unstructured":"Geda YE, Roberts RO, Mielke MM, Knopman DS, Christianson TJH, Pankratz VS, et al. Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: a population-based study. Am J Psychiatry. 2014;171:572\u201381. https:\/\/doi.org\/10.1176\/appi.ajp.2014.13060821.","journal-title":"Am J Psychiatry"},{"key":"701_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1159\/000357775","volume":"4","author":"SJ Banks","year":"2014","unstructured":"Banks SJ, Raman R, He F, Salmon DP, Ferris S, Aisen P, et al. The Alzheimer\u2019s disease cooperative study prevention instrument project: longitudinal outcome of behavioral measures as predictors of cognitive decline. Dement Geriatr Cogn Dis Extra. 2014;4:509\u201316. https:\/\/doi.org\/10.1159\/000357775.","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"701_CR12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1212\/WNL.0000000000001238","volume":"84","author":"MC Masters","year":"2015","unstructured":"Masters MC, Morris JC, Roe CM. \u201cNoncognitive\u201d symptoms of early Alzheimer disease: a longitudinal analysis. Neurology. 2015;84:617\u201322. https:\/\/doi.org\/10.1212\/WNL.0000000000001238.","journal-title":"Neurology"},{"key":"701_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jalz.2015.05.017","volume":"12","author":"Z Ismail","year":"2016","unstructured":"Ismail Z, Smith EE, Geda Y, Sultzer D, Brodaty H, Smith G, et al. Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dement. 2016;12:195\u2013202. https:\/\/doi.org\/10.1016\/j.jalz.2015.05.017.","journal-title":"Alzheimers Dement"},{"key":"701_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3233\/JAD-2012-120169","volume":"31","author":"H Brodaty","year":"2012","unstructured":"Brodaty H, Heffernan M, Draper B, Reppermund S, Kochan NA, Slavin MJ, et al. Neuropsychiatric symptoms in older people with and without cognitive impairment. J Alzheimers Dis. 2012;31:411\u201320. https:\/\/doi.org\/10.3233\/JAD-2012-120169.","journal-title":"J Alzheimers Dis"},{"key":"701_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jalz.2017.08.015","volume":"14","author":"I Acosta","year":"2018","unstructured":"Acosta I, Borges G, Aguirre-Hernandez R, Sosa AL, Prince M. Neuropsychiatric symptoms as risk factors of dementia in a Mexican population: a 10\/66 Dementia Research Group study. Alzheimers Dement. 2018;14:271\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2017.08.015.","journal-title":"Alzheimers Dement"},{"key":"701_CR16","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","volume":"10","author":"F Jessen","year":"2014","unstructured":"Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Ch\u00e9telat G, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease. Alzheimers Dement. 2014;10:844\u201352. https:\/\/doi.org\/10.1016\/j.jalz.2014.01.001.","journal-title":"Alzheimers Dement"},{"key":"701_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/J.JALZ.2012.08.004","volume":"9","author":"AC van Harten","year":"2013","unstructured":"van Harten AC, Visser PJ, Pijnenburg YAL, Teunissen CE, Blankenstein MA, Scheltens P, et al. Cerebrospinal fluid A\u03b242 is the best predictor of clinical progression in patients with subjective complaints. Alzheimers Dement. 2013;9:481\u20137. https:\/\/doi.org\/10.1016\/J.JALZ.2012.08.004.","journal-title":"Alzheimers Dement"},{"key":"701_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/J.JALZ.2009.10.002","volume":"6","author":"B Reisberg","year":"2010","unstructured":"Reisberg B, Shulman MB, Torossian C, Leng L, Zhu W. Outcome over seven years of healthy adults with and without subjective cognitive impairment. Alzheimers Dement. 2010;6:11\u201324. https:\/\/doi.org\/10.1016\/J.JALZ.2009.10.002.","journal-title":"Alzheimers Dement"},{"key":"701_CR19","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1001\/archgenpsychiatry.2010.30","volume":"67","author":"F Jessen","year":"2010","unstructured":"Jessen F, Wiese B, Bachmann C, Eifflaender-Gorfer S, Haller F, K\u00f6lsch H, et al. Prediction of dementia by subjective memory impairment effects of severity and temporal association with cognitive impairment. Arch Gen Psychiatry. 2010;67:414\u201322. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2010.30.","journal-title":"Arch Gen Psychiatry"},{"key":"701_CR20","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.jagp.2014.02.007","volume":"22","author":"NJ Donovan","year":"2014","unstructured":"Donovan NJ, Amariglio RE, Zoller AS, Rudel RK, Gomez-Isla T, Blacker D, et al. Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease. Am J Geriatr Psychiatry. 2014;22:1642\u201351. https:\/\/doi.org\/10.1016\/j.jagp.2014.02.007.","journal-title":"Am J Geriatr Psychiatry"},{"key":"701_CR21","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jalz.2018.10.003","volume":"15","author":"RER Slot","year":"2019","unstructured":"Slot RER, Sikkes SAM, Berkhof J, Brodaty H, Buckley R, Cavedo E, et al. Subjective cognitive decline and rates of incident Alzheimer\u2019s disease and non\u2013Alzheimer\u2019s disease dementia. Alzheimers Dement. 2019;15:465\u201376. https:\/\/doi.org\/10.1016\/j.jalz.2018.10.003.","journal-title":"Alzheimers Dement"},{"key":"701_CR22","doi-asserted-by":"publisher","unstructured":"Mitchell AJ, Beaumont H, Ferguson D, Yadegarfar M, Stubbs B. Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis. Acta Psychiatr Scand. 2014;130. https:\/\/doi.org\/10.1111\/acps.12336.","DOI":"10.1111\/acps.12336"},{"key":"701_CR23","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3233\/JAD-160407","volume":"54","author":"S Wolfsgruber","year":"2016","unstructured":"Wolfsgruber S, Kleineidam L, Wagner M, M\u00f6sch E, Bickel H, L\u03cbhmann D, et al. Differential risk of incident Alzheimer\u2019s disease dementia in stable versus unstable patterns of subjective cognitive decline. J Alzheimers Dis. 2016;54:1135\u201346. https:\/\/doi.org\/10.3233\/JAD-160407.","journal-title":"J Alzheimers Dis"},{"key":"701_CR24","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S1474-4422(09)70139-5","volume":"8","author":"PJ Visser","year":"2009","unstructured":"Visser PJ, Verhey F, Knol DL, Scheltens P, Wahlund L-O, Freund-Levi Y, et al. Prevalence and prognostic value of CSF markers of Alzheimer\u2019s disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. Lancet Neurol. 2009;8:619\u201327. https:\/\/doi.org\/10.1016\/S1474-4422(09)70139-5.","journal-title":"Lancet Neurol"},{"key":"701_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13195-017-0314-2","volume":"10","author":"F Jessen","year":"2018","unstructured":"Jessen F, Spottke A, Boecker H, Brosseron F, Buerger K, Catak C, et al. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer\u2019s disease (DELCODE). Alzheimers Res Ther. 2018;10:15. https:\/\/doi.org\/10.1186\/s13195-017-0314-2.","journal-title":"Alzheimers Res Ther"},{"key":"701_CR26","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/J.JALZ.2015.12.013","volume":"12","author":"RF Buckley","year":"2016","unstructured":"Buckley RF, Maruff P, Ames D, Bourgeat P, Martins RN, Masters CL, et al. Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer\u2019s disease. Alzheimers Dement. 2016;12:796\u2013804. https:\/\/doi.org\/10.1016\/J.JALZ.2015.12.013.","journal-title":"Alzheimers Dement"},{"key":"701_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13195-019-0515-y","volume":"11","author":"L Miebach","year":"2019","unstructured":"Miebach L, Wolfsgruber S, Polcher A, Peters O, Menne F, Luther K, et al. Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study. Alzheimers Res Ther. 2019;11:66. https:\/\/doi.org\/10.1186\/s13195-019-0515-y.","journal-title":"Alzheimers Res Ther"},{"key":"701_CR28","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/J.JALZ.2017.12.003","volume":"14","author":"BE Snitz","year":"2018","unstructured":"Snitz BE, Wang T, Cloonan YK, Jacobsen E, Chang C-CH, Hughes TF, et al. Risk of progression from subjective cognitive decline to mild cognitive impairment: the role of study setting. Alzheimers Dement. 2018;14:734\u201342. https:\/\/doi.org\/10.1016\/J.JALZ.2017.12.003.","journal-title":"Alzheimers Dement"},{"key":"701_CR29","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.1212\/WNL.0000000000005863","volume":"91","author":"AC van Harten","year":"2018","unstructured":"van Harten AC, Mielke MM, Swenson-Dravis DM, Hagen CE, Edwards KK, Roberts RO, et al. Subjective cognitive decline and risk of MCI: the Mayo Clinic Study of Aging. Neurology. 2018;91:e300\u201312. https:\/\/doi.org\/10.1212\/WNL.0000000000005863.","journal-title":"Neurology"},{"key":"701_CR30","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14:535\u201362. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018.","journal-title":"Alzheimers Dement"},{"key":"701_CR31","doi-asserted-by":"publisher","first-page":"P1136","DOI":"10.1016\/j.jalz.2017.06.1655","volume":"13","author":"S Wolfsgruber","year":"2017","unstructured":"Wolfsgruber S, Kleineidam L, Guski J, Peters O, Buerger K, Ewers M, et al. Latent-factor structure of the DELCODE study neuropsychological test battery. Alzheimers Dement. 2017;13:P1136\u20137. https:\/\/doi.org\/10.1016\/j.jalz.2017.06.1655.","journal-title":"Alzheimers Dement"},{"key":"701_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1176\/jnp.12.2.233","volume":"12","author":"DI Kaufer","year":"2000","unstructured":"Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, et al. Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory. J Neuropsychiatry Clin Neurosci. 2000;12:233\u20139. https:\/\/doi.org\/10.1176\/jnp.12.2.233.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"701_CR33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1300\/J018v05n01_09","volume":"5","author":"JA Yesavage","year":"1986","unstructured":"Yesavage JA, Sheikh JI. 9\/Geriatric depression scale (GDS) recent evidence and development of a shorter version. Clin Gerontol. 1986;5:165\u201373.","journal-title":"Clin Gerontol"},{"key":"701_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1300\/J018v01n01_06","volume":"1","author":"TL Brink","year":"1982","unstructured":"Brink TL, Yesavage JA, Lum O, Heersema PH, Adey M, Rose TL. Screening tests for geriatric depression. Clin Gerontol. 1982;1:37\u201343. https:\/\/doi.org\/10.1300\/J018v01n01_06.","journal-title":"Clin Gerontol"},{"key":"701_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1017\/S1041610210001237","volume":"23","author":"GJ Byrne","year":"2011","unstructured":"Byrne GJ, Pachana NA. Development and validation of a short form of the Geriatric Anxiety Inventory \u2013 the GAI-SF. Int Psychogeriatrics. 2011;23:125\u201331. https:\/\/doi.org\/10.1017\/S1041610210001237.","journal-title":"Int Psychogeriatrics"},{"key":"701_CR36","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/gps.2713","volume":"27","author":"RS MacKin","year":"2012","unstructured":"MacKin RS, Insel P, Aisen PS, Geda YE, Weiner MW. Longitudinal stability of subsyndromal symptoms of depression in individuals with mild cognitive impairment: relationship to conversion to dementia after 3 years. Int J Geriatr Psychiatry. 2012;27:355\u201363. https:\/\/doi.org\/10.1002\/gps.2713.","journal-title":"Int J Geriatr Psychiatry"},{"key":"701_CR37","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1037\/0894-4105.22.4.531","volume":"22","author":"ST Farias","year":"2008","unstructured":"Farias ST, Mungas D, Reed BR, Cahn-Weiner D, Jagust W, Baynes K, et al. The measurement of everyday cognition (ECog): scale development and psychometric properties. Neuropsychology. 2008;22:531\u201344. https:\/\/doi.org\/10.1037\/0894-4105.22.4.531.","journal-title":"Neuropsychology"},{"key":"701_CR38","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/acn3.274","volume":"3","author":"S Janelidze","year":"2016","unstructured":"Janelidze S, Zetterberg H, Mattsson N, Palmqvist S, Vanderstichele H, Lindberg O, et al. CSF A \u03b2 42\/A \u03b2 40 and A \u03b2 42\/A \u03b2 38 ratios: better diagnostic markers of Alzheimer disease. Ann Clin Transl Neurol. 2016;3:154\u201365. https:\/\/doi.org\/10.1002\/acn3.274.","journal-title":"Ann Clin Transl Neurol"},{"key":"701_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0165-0327(01)00453-0","volume":"72","author":"HC Comijs","year":"2002","unstructured":"Comijs HC, Deeg DJH, Dik MG, Twisk JWR, Jonker C. Memory complaints; the association with psycho-affective and health problems and the role of personality characteristics: a 6-year follow-up study. J Affect Disord. 2002;72:157\u201365. https:\/\/doi.org\/10.1016\/S0165-0327(01)00453-0.","journal-title":"J Affect Disord"},{"key":"701_CR40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1474-4422(19)30368-0","volume":"19","author":"F Jessen","year":"2020","unstructured":"Jessen F, Amariglio RE, Buckley RF, van der Flier WM, Han Y, Molinuevo JL, et al. The characterisation of subjective cognitive decline. Lancet Neurol. 2020;19:271\u20138. https:\/\/doi.org\/10.1016\/S1474-4422(19)30368-0.","journal-title":"Lancet Neurol"},{"key":"701_CR41","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/gps.4278","volume":"30","author":"F Stella","year":"2015","unstructured":"Stella F, Forlenza OV, Laks J, de Andrade LP, de Castilho CJ, Govone JS, et al. Caregiver report versus clinician impression: disagreements in rating neuropsychiatric symptoms in Alzheimer\u2019s disease patients. Int J Geriatr Psychiatry. 2015;30:1230\u20137. https:\/\/doi.org\/10.1002\/gps.4278.","journal-title":"Int J Geriatr Psychiatry"},{"key":"701_CR42","doi-asserted-by":"publisher","first-page":"jnnp-2020-32298","DOI":"10.1136\/jnnp-2020-322987","volume":"91","author":"TP Tavares","year":"2020","unstructured":"Tavares TP, Mitchell DGV, Coleman KK, Coleman BL, Shoesmith CL, Butler CR, et al. Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry. 2020;91:jnnp-2020-322987. https:\/\/doi.org\/10.1136\/jnnp-2020-322987.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"701_CR43","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3389\/fnagi.2019.00176","volume":"10","author":"JMS Escudero","year":"2019","unstructured":"Escudero JMS, Beltr\u00e1n J, Palacios \u00c1, Chimb\u00ed CM, Matallana D, Reyes P, et al. Neuropsychiatric symptoms as predictors of clinical course in neurodegeneration. A longitudinal study. Front Aging Neurosci. 2019;10:176. https:\/\/doi.org\/10.3389\/fnagi.2019.00176.","journal-title":"Front Aging Neurosci"},{"key":"701_CR44","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1176\/jnp.14.4.424","volume":"14","author":"MF Mendez","year":"2002","unstructured":"Mendez MF, Perryman KM. Neuropsychiatric features of frontotemporal dementia: evaluation of consensus criteria and review. J Neuropsychiatry Clin Neurosci. 2002;14:424\u20139. https:\/\/doi.org\/10.1176\/jnp.14.4.424.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"701_CR45","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1212\/WNL.0000000000005872","volume":"91","author":"F Jessen","year":"2018","unstructured":"Jessen F, Rodriguez N\u00e9e Then FS. Not all, but specific types of cognitive complaints predict decline to MCI. Neurology. 2018;91:153\u20134. https:\/\/doi.org\/10.1212\/WNL.0000000000005872.","journal-title":"Neurology"},{"key":"701_CR46","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3233\/JAD-160979","volume":"56","author":"Z Ismail","year":"2017","unstructured":"Ismail Z, Ag\u00fcera-Ortiz L, Brodaty H, Cieslak A, Cummings J, Fischer CE, et al. The Mild Behavioral Impairment Checklist (MBI-C): a rating scale for neuropsychiatric symptoms in pre-dementia populations. J Alzheimers Dis. 2017;56:929\u201338. https:\/\/doi.org\/10.3233\/JAD-160979.","journal-title":"J Alzheimers Dis"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00701-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-020-00701-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00701-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T05:59:57Z","timestamp":1634363997000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-020-00701-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,16]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["701"],"URL":"https:\/\/doi.org\/10.1186\/s13195-020-00701-7","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,16]]},"assertion":[{"value":"22 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the ethical committees of the medical faculties of all participating sites: the ethical committees of Berlin (Charit\u00e9, Universit\u00e4tsmedizin Berlin), Bonn, Cologne, G\u00f6ttingen, Magdeburg, Munich (Ludwig-Maximilians-University), Rostock, and T\u00fcbingen. The process was led and coordinated by the ethical committee of the medical faculty of the University of Bonn. The registration number of the trial at the ethical committee in Bonn is 117\/13. All participants provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests with regard to the content of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"131"}}